Israel Set to Receive 4 Million Doses of Coronavirus Vaccine Candidate
Israel signed the first part of an agreement with California-based Arcturus to have first access to its novel coronavirus vaccine.
“The health minister and the staff of his office, in cooperation with the National Security Council, are continually striving to ensure there will be vaccinations available for the residents of Israel,” the Health Ministry said in a statement Friday morning.
The deal signed with Arcturus Therapeutics Holdings Inc. – one of America’s leading clinical-stage messenger RNA medicines companies – is to receive some four million doses of the company’s COVID-19 vaccine candidate, LUNAR-COV-19.
For now, the ministry has signed a binding term sheet. The parties intend to finalize a comprehensive supply agreement within 30 days.
Israel media reported that Israel is meant to receive 4 million doses.
“We are very pleased to support Israel’s vaccination strategy,” said Arcturus president and CEO Joseph Payne. (JPost / VFI News)
Behold, I will bring to it health and healing, and I will heal them and reveal to them abundance of prosperity and security. —Jeremiah 33:6